DK1377316T3 - Farmaceutisk sammensætning på grundlag af azalider til lokal anvendelse i oftalmologien - Google Patents

Farmaceutisk sammensætning på grundlag af azalider til lokal anvendelse i oftalmologien

Info

Publication number
DK1377316T3
DK1377316T3 DK02732804T DK02732804T DK1377316T3 DK 1377316 T3 DK1377316 T3 DK 1377316T3 DK 02732804 T DK02732804 T DK 02732804T DK 02732804 T DK02732804 T DK 02732804T DK 1377316 T3 DK1377316 T3 DK 1377316T3
Authority
DK
Denmark
Prior art keywords
azalides
ophthalmology
pharmaceutical composition
composition based
local use
Prior art date
Application number
DK02732804T
Other languages
Danish (da)
English (en)
Inventor
Jacques Luyckx
Frederic Pilotaz
Original Assignee
Thea Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thea Lab filed Critical Thea Lab
Application granted granted Critical
Publication of DK1377316T3 publication Critical patent/DK1377316T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK02732804T 2001-04-12 2002-04-11 Farmaceutisk sammensætning på grundlag af azalider til lokal anvendelse i oftalmologien DK1377316T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0105114A FR2823441B1 (fr) 2001-04-12 2001-04-12 Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie et son procede de preparation
PCT/FR2002/001263 WO2002083178A1 (fr) 2001-04-12 2002-04-11 Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie

Publications (1)

Publication Number Publication Date
DK1377316T3 true DK1377316T3 (da) 2008-09-22

Family

ID=8862340

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02732804T DK1377316T3 (da) 2001-04-12 2002-04-11 Farmaceutisk sammensætning på grundlag af azalider til lokal anvendelse i oftalmologien

Country Status (31)

Country Link
US (1) US7064109B2 (de)
EP (1) EP1377316B1 (de)
JP (2) JP4558275B2 (de)
KR (1) KR100835002B1 (de)
CN (1) CN1496270B (de)
AR (1) AR034033A1 (de)
AT (1) ATE397460T1 (de)
BR (1) BRPI0208367B8 (de)
CA (1) CA2443728C (de)
CY (1) CY1108302T1 (de)
CZ (1) CZ300213B6 (de)
DE (1) DE60226962D1 (de)
DK (1) DK1377316T3 (de)
EA (1) EA008088B1 (de)
EG (1) EG23169A (de)
ES (1) ES2307754T3 (de)
FR (1) FR2823441B1 (de)
HK (1) HK1065708A1 (de)
HR (1) HRP20030907B1 (de)
HU (1) HU230459B1 (de)
MA (1) MA27005A1 (de)
MX (1) MXPA03009349A (de)
OA (1) OA12462A (de)
PA (1) PA8543401A1 (de)
PE (1) PE20021082A1 (de)
PL (1) PL204403B1 (de)
PT (1) PT1377316E (de)
SI (1) SI1377316T1 (de)
TN (1) TNSN03091A1 (de)
WO (1) WO2002083178A1 (de)
ZA (1) ZA200307718B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004017477D1 (de) * 2004-11-09 2008-12-11 Novagali Pharma Sa Öl-in-Wasser-Emulsion mit niedriger Konzentration des kationischen Mittels und positivem Zetapotential
FR2884716B1 (fr) * 2005-04-22 2009-08-21 Thea Sa Lab Utilisation de l'azithromycine pour la fabrication d'un medicament destine au traitement des infections oculaires
WO2007074904A1 (ja) * 2005-12-28 2007-07-05 Wakamoto Pharmaceutical Co., Ltd. 水性医薬組成物
CN101668511A (zh) * 2007-02-28 2010-03-10 阿西克斯医疗公司 正常化睑板腺分泌的方法和化合物
US20100158821A1 (en) * 2008-12-22 2010-06-24 Eastman Chemical Company Antimicrobial agents, compositions and products containing the same, and methods of using the compositions and products
CN101780105B (zh) * 2009-01-20 2011-09-28 沈阳兴齐制药有限公司 小牛血去蛋白提取物的滴眼液
EP2228058A1 (de) 2009-03-04 2010-09-15 Novagali Pharma S.A. Anionische Öl-in-Wasser-Emulsion mit Prostaglandinen und Verwendungen dafür
US8106111B2 (en) * 2009-05-15 2012-01-31 Eastman Chemical Company Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions
EP2389939A1 (de) 2010-05-28 2011-11-30 Novagali Pharma S.A. Verwendung von Prostaglandinen F2alpha und Analoga zur Heilung von Horn- und Bindehautläsionen
EP2394636B1 (de) * 2010-05-28 2014-03-19 Novagali Pharma S.A. Verfahren zur Behandlung von Netzhauterkrankungen mit einer intraokularen Tamponade
US9044508B2 (en) * 2013-03-15 2015-06-02 Insite Vision Corporation Concentrated aqueous azalide formulations
AU2017290256A1 (en) * 2016-06-29 2019-01-17 Otonomy, Inc. Triglyceride otic formulations and uses thereof
RS58292B1 (sr) * 2016-07-07 2019-03-29 Salvat Lab Sa Oftalmološka kompozicija sa ricinusovim uljem i srednjim lancem triglicerida

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1152644A (en) * 1966-07-01 1969-05-21 Abbott Lab Stable Solutions of Erythromycin Free Base
JPS6468328A (en) * 1987-09-09 1989-03-14 Suntory Ltd Anticorneoulcerative
JP2563336B2 (ja) * 1987-06-01 1996-12-11 エーザイ株式会社 角膜透過促進点眼剤
FR2746035B1 (fr) * 1996-03-15 1998-06-12 Microparticules de gel composite susceptibles d'etre utilisees comme vecteur(s) de principe(s) actif(s), l'un de leurs procedes de preparation et leurs applications
ES2221127T5 (es) * 1997-12-02 2009-11-10 Pfizer Products Inc. Uso de acitromicina en el tratamiento topico de infecciones oculares.
JP2000159659A (ja) * 1998-11-30 2000-06-13 Kazuo Tsubota 眼科用人工涙液
US6239113B1 (en) * 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections

Also Published As

Publication number Publication date
EP1377316B1 (de) 2008-06-04
CN1496270B (zh) 2010-05-26
TNSN03091A1 (fr) 2005-12-23
AR034033A1 (es) 2004-01-21
CY1108302T1 (el) 2014-02-12
CZ20032771A3 (cs) 2004-01-14
WO2002083178A1 (fr) 2002-10-24
PA8543401A1 (es) 2003-01-24
PT1377316E (pt) 2008-09-15
HUP0303864A2 (hu) 2004-03-01
MA27005A1 (fr) 2004-12-20
CA2443728A1 (fr) 2002-10-24
PE20021082A1 (es) 2002-12-18
BRPI0208367B8 (pt) 2021-05-25
ZA200307718B (en) 2004-09-02
OA12462A (fr) 2006-06-24
EA200301108A1 (ru) 2004-04-29
EP1377316A1 (de) 2004-01-07
FR2823441B1 (fr) 2004-09-10
US20040197340A1 (en) 2004-10-07
JP5170780B2 (ja) 2013-03-27
ES2307754T3 (es) 2008-12-01
HRP20030907B1 (en) 2010-04-30
FR2823441A1 (fr) 2002-10-18
EA008088B1 (ru) 2007-02-27
HRP20030907A2 (en) 2004-02-29
PL204403B1 (pl) 2010-01-29
JP2010043109A (ja) 2010-02-25
JP4558275B2 (ja) 2010-10-06
HUP0303864A3 (en) 2012-07-30
BR0208367B1 (pt) 2013-11-12
DE60226962D1 (de) 2008-07-17
HK1065708A1 (en) 2005-03-04
CA2443728C (fr) 2011-01-04
EG23169A (en) 2004-06-30
KR100835002B1 (ko) 2008-06-09
BR0208367A (pt) 2004-03-09
CN1496270A (zh) 2004-05-12
US7064109B2 (en) 2006-06-20
CZ300213B6 (cs) 2009-03-18
HU230459B1 (hu) 2016-07-28
KR20030088466A (ko) 2003-11-19
PL363538A1 (en) 2004-11-29
JP2004526763A (ja) 2004-09-02
MXPA03009349A (es) 2004-11-12
ATE397460T1 (de) 2008-06-15
SI1377316T1 (sl) 2008-10-31

Similar Documents

Publication Publication Date Title
FI20011478A0 (fi) Farmaseuttinen koostumus
DE60213592D1 (de) Flüssige pharmazeutische zusammensetzung
DE60127002D1 (de) Pharmazeutische zusammensetzung
NO20033384L (no) Farmasoytisk formulering
ITTO20010005A1 (it) Formulazione farmaceutica.
ITTO20000779A0 (it) Composizioni farmaceutiche.
AR028204A1 (es) Composiciones farmaceuticas electrohiladas
NO20033785D0 (no) Farmasöytisk formulering
PT1467724E (pt) Composicao farmaceutica orodispersavel de agomelatina
EE200300589A (et) Ravimkoostised
DK1377316T3 (da) Farmaceutisk sammensætning på grundlag af azalider til lokal anvendelse i oftalmologien
FI20022128A0 (fi) Farmaseuttinen koostumus
DE60217390D1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
ATE366128T1 (de) Pharmazeutische zusammensetzung
DE10291905D2 (de) Pharmazeutische Zusammensetzung
NO20032010D0 (no) Ikke-aspirerende overgangsviskosielastikker for anvendelse i kirurgi
EE200300465A (et) Püridoindolooni derivaatidel põhinevad farmatseutilised kompositsioonid
DE10107261B4 (de) Pharmazeutische Zusammensetzung
IT1318654B1 (it) Composizioni farmaceutiche comprendenti agenti antiinfiammatori e lorousi.
EE200200689A (et) Ravimkoostised
NO20041236L (no) Farmasoytisk formulering
FI5468U1 (fi) Farmaseuttinen koostumus
ITMI20032417A1 (it) Composizione farmaceutica particolarmente per uso dermatologico.
ES1051500Y (es) Dispositivo para aplicacion de farmacos fotosensibles en oftalmologia.
DOP2002000508A (es) Composición farmaceutica